Behcet’s syndrome – Diagnostics – Overview of Information and Clinical Research

Diagnosing Behçet’s syndrome can be challenging because there is no single test that confirms the condition, and symptoms often overlap with other diseases. The process relies on careful observation of symptoms over time, combined with specific tests to rule out other conditions and look for characteristic patterns of inflammation throughout the body.

Introduction: Who Should Seek Diagnostic Evaluation

Anyone experiencing repeated episodes of painful mouth sores that don’t seem to follow the pattern of ordinary canker sores should consider seeking medical evaluation. If these mouth sores are accompanied by other symptoms like genital ulcers, eye inflammation, or unusual skin rashes, the need for a professional assessment becomes even more important.^[1]

People who notice that their symptoms come and go in cycles, appearing for weeks and then disappearing for a time, should pay attention to this pattern. This recurring nature is one of the hallmarks of Behçet’s syndrome. If you’ve had at least three episodes of mouth ulcers in the past year along with other unexplained symptoms, it’s time to talk to a doctor.^[3]

Since Behçet’s syndrome most commonly begins to show symptoms in people between the ages of 20 and 30, young adults experiencing these patterns should be particularly aware. However, the condition can affect anyone at any age, including children and older adults, so age alone should not prevent someone from seeking evaluation.^[2]

Individuals from regions along the historic Silk Road, including Turkey, the Mediterranean basin, Middle East, and Far East, have a higher likelihood of developing this condition. People of Mediterranean, Middle Eastern, or Asian descent living anywhere in the world should be aware of their increased risk and seek evaluation if symptoms appear.^[4]

⚠️ Important

If you develop sudden vision problems, severe headaches with fever and stiff neck, or symptoms suggesting a stroke, seek immediate medical attention. These could indicate serious complications of Behçet’s syndrome affecting the brain or eyes, which require urgent treatment to prevent permanent damage.

Classic Diagnostic Methods

Diagnosing Behçet’s syndrome is not straightforward because no single laboratory test or imaging scan can definitively prove you have the condition. Instead, doctors rely primarily on observing your symptoms over time and ruling out other diseases that might cause similar problems. This approach is called clinical diagnosis, meaning the diagnosis is based on the pattern of symptoms rather than a specific test result.^[8]

The foundation of diagnosis rests on identifying recurring mouth sores. Nearly everyone with Behçet’s syndrome experiences painful mouth ulcers at some point, making this the most consistent sign doctors look for. Current guidelines suggest that a person needs to have experienced at least three separate episodes of mouth ulcers within a twelve-month period for a diagnosis to be considered.^[3]

Beyond the mouth sores, doctors look for at least two additional symptoms from a specific list. These include genital ulcers that keep coming back, eye inflammation causing redness or vision problems, skin sores or unusual skin reactions, or what doctors call pathergy, which is an oversensitive skin reaction. Each of these symptoms helps paint a clearer picture of whether Behçet’s syndrome is present.^[8]

The Pathergy Test

One distinctive diagnostic tool used for Behçet’s syndrome is the pathergy test. During this simple procedure, a healthcare provider inserts a sterile needle into the skin of your forearm, creating a tiny injury. The area is then checked one to two days later. In people with Behçet’s syndrome, the immune system often overreacts to this minor injury, forming a small red bump or pustule at the needle site. This reaction shows that the body’s immune system responds too strongly to even minimal trauma.^[8]

However, the pathergy test isn’t positive in everyone with Behçet’s syndrome. It tends to be more commonly positive in people from regions where the disease is more prevalent, such as Turkey and the Middle East, and less common in people from Western countries. Because of this variation, a negative pathergy test doesn’t rule out Behçet’s syndrome, but a positive test can provide helpful supporting evidence.^[2]

Blood Tests and Laboratory Work

While no blood test can confirm Behçet’s syndrome, blood tests play an important role in the diagnostic process. Doctors order various blood tests primarily to rule out other conditions that might cause similar symptoms. These tests check for signs of other autoimmune diseases, infections, or inflammatory conditions that could explain what you’re experiencing.^[6]

Some doctors may check for a genetic marker called HLA-B51 (sometimes written as HLA-B5). This gene is more common in people with Behçet’s syndrome, especially those from high-risk geographic regions. However, carrying this gene doesn’t mean you definitely have the disease, and not having it doesn’t mean you don’t have Behçet’s syndrome. The gene test alone cannot confirm or rule out the diagnosis on its own.^[6]

Blood tests may also reveal general signs of inflammation in the body, though these findings are not specific to Behçet’s syndrome. The results help doctors understand the overall level of disease activity and inflammation affecting your body, which can guide treatment decisions even if they don’t provide a definitive diagnosis.^[2]

Urine and Other Laboratory Tests

Urine tests are sometimes performed as part of the diagnostic workup. Like blood tests, urine analysis helps doctors look for signs of kidney involvement or rule out infections and other conditions. If the disease has affected the kidneys or urinary tract, urine tests may reveal abnormalities that warrant further investigation.^[3]

Imaging Studies

Various imaging tests may be ordered depending on which parts of your body are showing symptoms. X-rays can help doctors see if joints are affected or if there’s damage to bones. A CT scan (computed tomography) or MRI (magnetic resonance imaging) might be used to examine blood vessels, the brain, or internal organs if doctors suspect these areas are involved.^[3]

When Behçet’s syndrome affects the nervous system, brain imaging becomes particularly important. An MRI can reveal areas of inflammation in the brain or brainstem, showing damage to what doctors call the “white matter” portion of the brain. These changes help confirm that the neurological symptoms are related to Behçet’s syndrome rather than another condition.^[7]

If blood vessel problems are suspected, specialized scans called angiography may be performed to look at arteries and veins throughout the body. These tests can reveal dangerous complications like aneurysms, which are balloon-like bulges in blood vessel walls caused by inflammation, or blocked vessels that could lead to serious problems if left untreated.^[7]

Eye Examinations

Because eye involvement is so common and potentially serious in Behçet’s syndrome, a thorough eye examination by an ophthalmologist is often a critical part of the diagnostic process. The eye doctor looks for specific types of inflammation both in the front part of the eye (anterior uveitis) and the back part of the eye (posterior uveitis).^[2]

Posterior uveitis can be especially dangerous because it may damage the retina without causing obvious symptoms initially. Regular eye examinations help catch these problems early, before permanent vision loss occurs. The pattern and type of eye inflammation seen during these exams provide important clues about whether Behçet’s syndrome is the underlying cause.^[7]

Skin and Tissue Biopsies

In some cases, doctors may perform a biopsy, which means taking a small sample of affected tissue to examine under a microscope. Skin biopsies can help distinguish Behçet’s-related skin lesions from other skin conditions. While the biopsy findings aren’t specific enough to diagnose Behçet’s syndrome on their own, they add another piece to the diagnostic puzzle.^[3]

Ruling Out Other Conditions

A crucial part of diagnosing Behçet’s syndrome involves making sure the symptoms aren’t caused by something else. Many conditions can cause mouth sores, genital ulcers, or eye inflammation, so doctors must carefully consider and exclude other possibilities. These might include other autoimmune diseases, certain infections, inflammatory bowel diseases, or other types of vasculitis (inflammation of blood vessels).^[3]

The process of ruling out other conditions is why diagnosis can take time and may require multiple appointments and tests. Doctors need to see how symptoms evolve over weeks or months and observe whether the pattern truly fits Behçet’s syndrome rather than another illness.^[8]

Specialist Evaluation

Because Behçet’s syndrome can affect so many different parts of the body, people seeking diagnosis often see multiple specialists. A rheumatologist, who specializes in diseases affecting joints and the immune system, typically coordinates the diagnostic process. Other specialists might include a dermatologist for skin symptoms, an ophthalmologist for eye problems, or a neurologist if the nervous system is affected.^[3]

In some countries, specialized Behçet’s disease centers exist where teams of experts work together to diagnose and treat the condition. These centers have extensive experience with the disease and can provide coordinated evaluation when the diagnosis is uncertain or the symptoms are complex.^[3]

⚠️ Important

Getting an accurate diagnosis may take time, sometimes several months or longer. This waiting period can be frustrating, but it’s necessary because doctors need to observe symptom patterns and rule out other conditions. Keep detailed records of your symptoms, including when they occur, how long they last, and any triggers you notice. Photographs of skin or mouth lesions can be especially helpful during medical appointments.

Diagnostics for Clinical Trial Qualification

When patients with Behçet’s syndrome consider participating in research studies or clinical trials, additional diagnostic criteria often come into play. Clinical trials have specific entry requirements to ensure that participants truly have the condition being studied and that results will be meaningful. These requirements are usually more stringent than those used for routine diagnosis in clinical practice.^[8]

Most clinical trials require documentation of recurrent oral ulcers as a baseline criterion, typically needing evidence of at least three episodes within a specified timeframe, often twelve months. This documentation might come from medical records, photographs taken during active disease periods, or examinations performed by the trial investigators when ulcers are present.^[17]

Trials often require at least two additional symptoms from a defined list, similar to standard diagnostic criteria but sometimes with stricter definitions. For example, a trial might require documented genital ulcers confirmed by physical examination rather than just patient reporting. Eye involvement might need to be verified by an ophthalmologist using specific examination techniques to document the type and severity of inflammation.^[6]

Some research studies measure disease activity using standardized scoring systems. These systems assign numerical values to different symptoms and their severity, creating an overall activity score. Patients may need to have a minimum disease activity score to qualify for certain trials, particularly those testing new treatments. The scoring helps ensure that participants have active disease that might respond to the treatment being studied.^[10]

Blood tests take on additional importance in clinical trial screening. While routine diagnosis may not require extensive laboratory work beyond ruling out other conditions, trials often mandate specific baseline blood tests. These might include complete blood counts, liver and kidney function tests, tests for specific infections, and markers of inflammation. Some trials exclude people whose blood tests show certain abnormalities that might interfere with the study medication or make participation unsafe.^[2]

Genetic testing for HLA-B51 might be required or preferred in some clinical trials. Research has shown that people with this genetic marker may respond differently to certain treatments, so some studies specifically recruit participants who carry this gene or analyze results separately based on genetic status. However, the absence of this gene doesn’t automatically exclude someone from most trials.^[4]

Imaging studies often form part of the screening process for clinical trials, particularly for studies focusing on specific organ involvement. Trials investigating eye treatments might require detailed eye examinations including specialized imaging of the retina. Studies of vascular complications might mandate CT scans or MRI imaging to document the extent of blood vessel involvement before treatment begins.^[7]

Clinical trials typically require participants to meet very specific criteria regarding previous treatments. Some trials look for people who haven’t responded adequately to standard medications, requiring documentation of treatment failure. Others might specifically recruit patients who have never received certain types of treatment, wanting to study how treatment-naive patients respond. Medical records showing complete treatment history become essential documents for trial qualification.^[10]

The pathergy test sometimes plays a role in clinical trial enrollment, particularly in studies conducted in regions where positive pathergy is more common. Some research protocols use pathergy status to stratify participants into subgroups, helping researchers understand whether treatment effects differ between pathergy-positive and pathergy-negative patients.^[8]

Documentation requirements for clinical trials are typically much more extensive than for routine care. Participants need comprehensive medical records showing diagnosis, symptom history, all previous treatments with dates and doses, and results from all relevant tests. This documentation helps ensure proper trial enrollment and provides baseline data for comparison as the study progresses.^[10]

Prognosis and Survival Rate

Prognosis

The outlook for people living with Behçet’s syndrome varies considerably from person to person. For most individuals, the disease can be managed effectively with appropriate treatment, allowing them to maintain relatively normal lives. The condition tends to be most severe during the early years after symptoms begin, but disease activity often decreases as patients reach their forties and beyond.^[10]

Several factors influence how the disease progresses. Men, particularly those who develop symptoms at a younger age, tend to experience more severe disease than women. The specific organs affected also play a major role in determining outcomes. Eye involvement, vascular complications affecting large blood vessels, neurological problems, and gastrointestinal involvement are considered more serious manifestations that can lead to significant complications if not treated promptly and effectively.^[10]

One of the defining characteristics of Behçet’s syndrome is its pattern of flares and remissions. Symptoms can disappear completely for weeks, months, or even years at a time, only to return unexpectedly. This unpredictable nature makes the condition challenging to live with, but many people find that with proper treatment, flares become less frequent and less severe over time.^[1]

The most serious risk relates to potential complications affecting critical organs. Eye inflammation can lead to vision loss or blindness if not treated aggressively, though this outcome is less common in Western countries than in the Middle East and Japan. Inflammation affecting the brain or spinal cord can cause permanent neurological damage. Blood vessel involvement can lead to aneurysms that may rupture or blood clots that could cause life-threatening complications.^[2]

Early diagnosis and prompt treatment significantly improve outcomes. Starting appropriate therapy before irreversible organ damage occurs gives patients the best chance of maintaining their health and quality of life. Regular monitoring by healthcare providers helps catch complications early, allowing for treatment adjustments before serious problems develop.^[10]

Many patients experience improvement in their symptoms over the long term, particularly in mucocutaneous manifestations like mouth and genital ulcers. Joint symptoms often resolve without causing permanent damage. However, the course of the disease remains unpredictable, and continued medical supervision remains important throughout life.^[1]

Survival Rate

Overall survival for people with Behçet’s syndrome is generally good, with most patients having a normal or near-normal life expectancy. Death related to Behçet’s syndrome occurs in approximately 4 percent of cases, meaning that 96 percent of people with the condition do not die from disease-related causes.^[15]

When deaths do occur due to Behçet’s syndrome, they are typically caused by severe complications affecting vital organs. The most common causes include rupture of large artery aneurysms, particularly in the lungs, which can cause massive internal bleeding. Stroke resulting from blood vessel inflammation in the brain represents another potential cause of death. Perforation of the gastrointestinal tract, where ulcers create holes allowing intestinal contents to leak into the abdominal cavity, can also be life-threatening.^[15]

Cardiac involvement, while rare, can be serious when it occurs. Inflammation affecting the heart or the blood vessels supplying the heart may lead to fatal complications in some cases. These serious outcomes underscore the importance of comprehensive monitoring and aggressive treatment when major organs are involved.^[1]

The prognosis has improved significantly in recent decades with better understanding of the disease and more effective treatments. Modern medications, particularly biological therapies that target specific components of the immune system, have changed outcomes for many patients who previously would have faced serious complications. Early recognition of the disease and prompt initiation of appropriate therapy continue to be the most important factors in improving survival and quality of life.^[10]

#1 Clinical Trials Search in Europe